NCT00194948

Brief Summary

This study will determine the effectiveness of offering primary care patients their preferred treatment versus one that is less desirable in improving treatment adherence and outcome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2003

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2003

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

September 12, 2005

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 19, 2005

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2007

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2007

Completed
Last Updated

November 4, 2013

Status Verified

November 1, 2013

Enrollment Period

3.6 years

First QC Date

September 12, 2005

Last Update Submit

November 1, 2013

Conditions

Major Depression

Outcome Measures

Primary Outcomes (2)

  • treatment initiation

  • treatment adherence

Secondary Outcomes (1)

  • depressive symptomatology

Interventions

escitalopramDRUG
interpersonal psychotherapyBEHAVIORAL

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 21-99
  • English-speaking
  • DSM-IV criteria for major depression

You may not qualify if:

  • unable to give informed consent
  • MMSE\<24
  • DSM-IV diagnosis of bipolar disorder, psychotic disorder, current alcohol or substance abuse
  • active suicide ideation
  • aphasia
  • acute or severe medical illness
  • currently receiving either antidepressant medication or psychotherapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Cornell Internal Medicine Associates

New York, New York, 10021, United States

Location

Weill Medical College of Cornell University

White Plains, New York, 10605, United States

Location

MeSH Terms

Conditions

Depressive Disorder, Major

Interventions

EscitalopramInterpersonal Psychotherapy

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental Disorders

Intervention Hierarchy (Ancestors)

PropylaminesAminesOrganic ChemicalsNitrilesBenzofuransHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Patrick J Raue, PhD

    Weill Medical College of Cornell University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 12, 2005

First Posted

September 19, 2005

Study Start

September 1, 2003

Primary Completion

April 1, 2007

Study Completion

May 1, 2007

Last Updated

November 4, 2013

Record last verified: 2013-11

Locations

US(2)